VAERS 975372
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN5348
- Staat
- NC
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 11.02.2021
- Impfdatum
- 26.01.2021
- Beginn
- 26.01.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Symptomtext
He states he received the vaccine and within 2-3 minutes he experienced dizziness, chest tightness affecting breathing, tunnel vision, disorientation. He asked for help and first they walked him to a chair and then laid him down. He recalls the MD taking his pulse and reporting it as 140. He states his awareness was blurred, but he remembers receiving the epi pen and then feeling better. He recalls sweating but not sure if it was before or after epinephrine. EMS arrived, started an IV and transported him to ER. He denies recalling pruritis, urticaria, oral face throat or tongue swelling, watery eyes, chest pain, cough, wheeze, nausea or emesis. ER observed him several hours. His discharge diagnosis was syncope. He denies recent use of antihistamines or H2 blockers. Per chart review, provider at the event recorded patient c/o hot dizzy, tachycardia, erythema bilat arms, chest with extension to the neck, diaphoresis, difficulty responding (single word only); treated with epinephrine with improved response.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- OSA
- Andere Medikamente
- Tylenol, naprosyn
- Allergien
- Presumed anaphylaxis to H1N1 influenza vaccine in 2009
- Vorherige Impfungen
- H1N1 influenza in 2009 (age 26)